User:Mr. Ibrahem/Dolasetron

Dolasetron, sold under the brand name Anzemet, is a medication used for postoperative and chemotherapy-induced nausea and vomiting. Other uses may include gastroenteritis and hyperemesis gravidarum. It does not work for motion sickness. It is taken by mouth; and less commonly by injection into a vein.

Common side effects include headache, tiredness, dizziness, and diarrhea. Other side effects may include QT prolongation and anaphylaxis. While there is no evidence of harm in pregnancy, such use is not well studied. It is a 5-HT3 receptor blocker.

Dolasetron was patented in 1986 and approved for medical use in 1997. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. In the United States it costs about 75 USD per dose. Some versions have been discontinued in the United States.